
%201.webp)



%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


%201.webp)



%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


As DSCSA enforcement continues to reshape pharmaceutical track-and-trace requirements, accurate location identification is just as critical as serialized product data. At the center of DSCSA-compliant traceability is the Global Location Number (GLN).
A GLN is the standardized identifier used to define who is involved and where events occur in pharmaceutical transactions. Within EPCIS data exchange, GLNs identify business locations, physical handling sites, and legal trading partners. Without accurate GLNs, DSCSA compliance and EPCIS interoperability break down.
Yet many organizations still ask:
Our GLN Compliance Guide Series provides a complete, practical explanation of GLN requirements, GLN management, and GLN best practices for DSCSA and EPCIS compliance.
A Global Location Number (GLN) is a 13-digit identifier issued by GS1 that uniquely identifies either:
The GLN meaning is straightforward: it is the globally recognized number that tells trading partners exactly which organization or location is involved in a supply chain event.
Under DSCSA, GLNs are required to accurately represent where serialized product events occur. In EPCIS files, GLNs serve as location identifiers within event data, ensuring traceability aligns with real-world operations.
Every trading partner participating in DSCSA track-and-trace must understand what a GLN is and how it functions within EPCIS data exchange.
GLNs are not administrative details—they are core compliance identifiers within DSCSA and EPCIS systems.
Whether you are:
Strong GLN management reduces EPCIS rejections, prevents data mismatches, and strengthens DSCSA compliance readiness.
Our GLN Compliance Guide Series provides a structured, role-based explanation of GLN requirements across the pharmaceutical supply chain.
The following GLN compliance guides address the most common GLN questions across manufacturers, wholesalers, pharmacy chains, and independent pharmacies.
This guide explains:
This guide explains:
This guide explains:
This guide explains:
This guide explains:
This guide explains:
This guide focuses on preventing DSCSA interoperability failures through accurate GLN configuration in outbound EPCIS files.
This guide explains:
This guide addresses scalable GLN governance for large pharmacy organizations operating under DSCSA requirements.
This guide explains:
This guide provides practical GLN compliance steps tailored to independent pharmacies preparing for DSCSA enforcement.
Accurate Global Location Numbers are essential to DSCSA compliance and reliable EPCIS traceability. Organizations that proactively manage GLNs—by verifying structure, eliminating duplicates, validating trading partner alignment, and auditing internal systems—reduce the risk of EPCIS rejection and compliance disruption.
With extensive experience in DSCSA interoperability, EPCIS validation, and pharmaceutical traceability systems, LSPedia works alongside manufacturers, wholesalers, 3PLs, health systems, and pharmacies to to improve product data accuracy and operational reliability across supply chain systems. This GLN Compliance Guide Series reflects that hands-on expertise and commitment to advancing compliant, scalable track-and-trace operations.
If you would like to learn more about LSPedia’s DSCSA compliance solutions, EPCIS services, or interoperability support, visit our website or contact our team to speak with a traceability expert.